Velico's Partnership with South Texas Blood Center Revolutionizes Plasma Access
Transforming Plasma Access with Innovative Technology
In a historic move, the South Texas Blood and Tissue Center (STBT) has become the first civilian blood center in the U.S. to adopt Velico, Inc.'s revolutionary FrontlineODP™ system. This groundbreaking partnership aims to enhance emergency medical practices by providing on-demand spray-dried plasma, making life-saving transfusions more accessible in critical situations.
The Role of Velico's FrontlineODP™ System
Located in Beverly, Massachusetts, Velico Inc. has made waves in the medical technology sphere with its FrontlineODP™ Spray Dried Plasma System. This innovative technology is specifically designed to produce plasma that remains stable at ambient temperatures, allowing it to be quickly reconstituted and ready for use within about two and a half minutes. Such rapid accessibility is crucial in emergency scenarios where frozen plasma products simply can’t be used effectively.
Implications for Emergency Medical Services
The applications of this technology are vast. The FrontlineODP™ system offers significant advantages to first responders, such as ground and air ambulances. It also proves beneficial for rural hospitals that don’t typically store plasma, military operations, and mass casualty events where immediate access to plasma can drastically improve patient outcomes. Richard Meehan, President and CEO of Velico Medical, emphasizes the system's potential to transform emergency medical services and save countless lives every year.
Insights from the Collaboration
As part of the Blood Center Education Program (BCEP), STBT is not just a participant; they are paving the way for future advancements. Their role includes providing invaluable feedback on the system's commission process and operational efficiency. Their involvement signifies progress in equipping emergency medical providers with tools that can make a real difference in patient care.
Expert Perspectives on the Partnership
Audra Taylor, Executive Director of Blood Operations at STBT, shares her optimism about the collaboration. She believes this system will significantly enhance their ability to provide critical plasma supplies where conventional liquid blood products are unavailable. The partnership highlights the aim of enhancing best practices in service and preparing customers for commercial readiness as they gear up for the future launch of FrontlineODP™.
Challenges and Regulations
Despite the great promise of the FrontlineODP™ system, it is crucial to acknowledge that it is still under investigation and has not yet received FDA approval for any applications. Velico's development is backed partly by federal funds, showing strong governmental support for innovations aimed at reducing preventable deaths from bleeding.
About Velico and South Texas Blood and Tissue Center
Velico, Inc. is committed to changing the landscape of blood transfusion and improving emergency medical responses. They have built significant expertise in transfusion medicine and device innovation. Meanwhile, the South Texas Blood and Tissue Center plays a vital role by supplying blood components to over one hundred local hospitals, supporting critical therapy advancements as part of the BioBridge Global non-profit family.
Frequently Asked Questions
What is the FrontlineODP™ system?
The FrontlineODP™ system is a technology developed by Velico that produces on-demand spray-dried plasma, allowing for quick preparation and use in emergencies.
How does this system improve patient care in emergencies?
By providing plasma that can be reconstituted within two and a half minutes, it allows for rapid transfusion in critical situations, where conventional methods may not be feasible.
Who will benefit from the FrontlineODP™ system?
First responders, rural hospitals, and military applications will significantly benefit from the easy accessibility of this plasma product.
Is the FrontlineODP™ system FDA approved?
Currently, the FrontlineODP™ system is still under investigation and has not received FDA approval yet for any specific uses.
What organizations are involved in this collaboration?
The partnership involves Velico, Inc., South Texas Blood and Tissue Center, and BioBridge Global, all working together to enhance blood transfusion practices.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
